| 阿德福韦酯治疗拉米夫定耐药慢性乙型肝炎126例疗效观察 |
| |
| 引用本文： | 朱培福.阿德福韦酯治疗拉米夫定耐药慢性乙型肝炎126例疗效观察[J].中国现代医生,2007,45(24):90-91. |
| |
| 作者姓名： | 朱培福 |
| |
| 作者单位： | 江苏省张家港市第一人民医院传染科 江苏张家港215600 |
| |
| 摘 要： | 目的探讨阿德福韦酯治疗拉米夫定耐药慢性乙型肝炎的临床疗效及安全性。方法选择126例拉米夫定耐药的慢性乙型肝炎患者予以阿德福韦酯10mg/d,疗程1年。于治疗前和治疗3、6、12个月检测肝、肾功能,HBV-DNA定量,HbeAg,抗HBe,观察药物不良反应。结果治疗3、6、12个月时,HBV-DNA定量随用药时间延长逐渐下降,HBV-DNA转阴率及HBeAg阴转率随用药时间延长逐渐上升,ALT复常率随用药时间延长逐渐上升,常见不良反应有轻微乏力、右上腹不适、腹胀。结论阿德福韦酯片治疗拉米夫定耐药慢性乙型肝炎,可在病毒学及生物化学方面取得较好疗效,且安全性良好。
|
| 关 键 词： | 慢性乙型肝炎 拉米夫定耐药 阿德福韦酯 |
| 文章编号： | 1673-9701(2007)24-90-03 |
| 修稿时间： | 2007年10月19 |
The Curative Effect Observation of Adefovir Dipivoxil for Lamivudine-resistant Chronic Hepatitis B(A Report of 126 Cases) |
| |
| Authors: | ZHU Peifu |
| |
| Abstract: | Objective To discuss the clinical efficacy and safety of adefovir dipivoxil for lamivudine-resistant chronic hepatitis B. Methods We chose 126 lamivudine-resistant chronic hepatitis B patients who were given to adefovir dipivoxil 10mg per day,which lasts for one year. Before treatment,and after 3,6,12 months,we detected liver function,HBV-DNA ration,HBeAg,anti-HBe,and adverse drug reactions respectively. Results With treatment, HBV-DNA ration has been gradually declining with extended medication use,HBV DNA-negative rate and clearance rate of HBeAg gradually increased with medication time,ALT normalization rate gradually rise with the drug extended,and common adverse reactions were mild weakness,right upper abdominal discomfort,and abdominal distension. Conclusion Adefovir dipivoxil in the treatment of lamivudine-resistant chronic hepatitis B,has better efficacy in biochemistry and virology,and its safety is good. |
| |
| Keywords: | Chronic hepatitis B Lamivudine-resistant Adefovir Dipivoxil |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
|
